IMDELLTRA (tarlatamab-dlle) for injection

IMDELLTRA is a prescription medicine used to treat extensive-stage small cell lung cancer (ES-SCLC) called a T-cell engager. FDA approved tarlatamab-dlle (brand name IMDELLTRA) is not (yet) registered or available in India but on request Indian patient can buy IMDELLTRA at the lowest price.

IMDELLTRA
IMDELLTRA (tarlatamab-dlle) for injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

IMDELLTRA (tarlatamab-dlle) for injection

Tarlatamab-dlle is used for treatment of advanced small cell lung cancer (SCLC) that has progressed on or after other treatments. Tarlatamab-dlle is in a class of medications called bispecific T-cell engager antibodies. It works by slowing or stopping the growth of cancer cells in your body.

IMDELLTRA is a prescription medicine used to treat adults with extensive stage small cell lung cancer (ES-SCLC), which is cancer that has spread throughout the lung or to other parts of the body, and who have received treatment with  chemotherapy that contains platinum, and it did not work or is no longer working.

Tarlatamab-dlle is used for treatment of advanced small cell lung cancer (SCLC) that has progressed on or after other treatments. Tarlatamab-dlle is in a class of medications called bispecific T-cell engager antibodies. It works by slowing or stopping the growth of cancer cells in your body.

IMDELLTRA (tarlatamab-dlle) for injection, for intravenous use Initial U.S. Approval: 2024
—————-
Current Indication: Treat small cell lung cancer (ES-SCLC) called a T-cell engager
—————-
Marketed By: Amgen Inc
—————-
Approval Date: : 2024
—————-
Active ingredients: tarlatamab-dlle
—————-
Inactive ingredients: glutamic acid, polysorbate 80, sucrose, and sodium hydroxide.
Inactive ingredients of IV Solution Stabilizer: citric acid monohydrate, lysine hydrochloride, polysorbate 80, sodium
hydroxide and water for Injection
—————-

For injection: 1 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution.
For injection: 10 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.